Risk of Acne in Patients With Atopic Dermatitis Starting a JAK Inhibitor vs Th2 Cytokine Inhibitor
This cohort study evaluates the risk of acne in adult patients with atopic dermatitis who started treatment with Janus kinase inhibitors compared with Th2 cytokine inhibitors.
Authors
- Priyanka Anand (ORCID: https://orcid.org/0000-0002-0945-4100)
- Maria C. Schneeweiss (ORCID: https://orcid.org/0000-0002-4304-5271)
- Joseph Frank Merola (ORCID: https://orcid.org/0000-0001-6514-4353)
- Michael R. Nock (ORCID: https://orcid.org/0009-0009-7462-1241)
- R GLYNN
- Yinzhu Jin
- Arash Mostaghimi
- David Rosmarin
- Richard Wyss
- Jonathan I. Silverberg
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- George Washington University (US)
- American Pharmacists Association (US)
- Southwestern Medical Center (US)
- Indiana University – Purdue University Indianapolis (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- JAMA Dermatology
- Published
- 2026-01-21
- DOI
- https://doi.org/10.1001/jamadermatol.2025.5443
- Citations
- 1
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 54.66